Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
41.11
+2.86 (7.48%)
At close: Nov 22, 2024, 4:00 PM
41.33
+0.22 (0.54%)
After-hours: Nov 22, 2024, 7:56 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $15.82 billion as of November 22, 2024. Its market cap has decreased by -43.67% in one year.
Market Cap
15.82B
Enterprise Value
7.97B
1-Year Change
-43.67%
Ranking
Category
Stock Price
$41.11
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $15.82B, an increase of 158.56%. That is a compound annual growth rate of 17.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molina Healthcare | 16.94B |
| Baxter International | 16.84B |
| United Therapeutics | 16.40B |
| Viatris | 15.82B |
| Royalty Pharma | 15.55B |
| Tenet Healthcare | 14.07B |
| Avantor | 13.86B |
| Summit Therapeutics | 13.58B |